PHARMACOLOGICAL CHARACTERIZATION OF THE CS1P1 COMPOUND AS A S1P1 RECEPTOR ANTAGONIST
Gorka Pereira Castelo,
Jonatan Martínez-Gardeazabal,
Iker Bengoetxea De Tena,
Marta Moreno-Rodríguez,
Hao Jiang,
Tu Zhude,
Iván Manuel,
Rafael Rodríguez-Puertas
Affiliations
Gorka Pereira Castelo
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain
Jonatan Martínez-Gardeazabal
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain
Iker Bengoetxea De Tena
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain
Marta Moreno-Rodríguez
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain
Hao Jiang
Washington University School of Medicine, Department Of Radiology, Saint Louis, United States of America
Tu Zhude
Washington University School of Medicine, Department Of Radiology, Saint Louis, United States of America
Iván Manuel
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain; BioCruces Bizkaia Health Research Institute, Neurodegenerative Diseases, Barakaldo, Spain
Rafael Rodríguez-Puertas
University of the Basque Country (UPV/EHU), Department Of Pharmacology, Faculty Of Medicine And Nursing, Leioa, Spain; BioCruces Bizkaia Health Research Institute, Neurodegenerative Diseases, Barakaldo, Spain
